semaglutide covered by insurance for weight loss coverage just changed as many as 56 million Americans when it comes to the popular GLP-1 medications used to promote loss. https://fox5sandiego.com/news/glp-1-insurance-change-impacts-millions-of-americans-what-to-know-how-to-tell The Guide for Malpractice Insurance

Little or no evidence was found for the effect of SGLT-2 inhibitors or GLP-1 receptor agonists on limb amputation, blindness, eye disease, neuropathic pain, or health related quality of life

Nevertheless, even the most effective marketed incretin, the GLP-1/GIP dual agonist tirzepatide, produces a maximum HbA1c reduction of ~2.6%, with fewer than half of participants in the SURPASS trials reaching normoglycemia (HbA1c 10%), vehicle-treated animals lost ~40% of body weight over 3 months, consistent with prior reports showing comparable reductions from ~40 g at week 10 to ~25 g by week 20 19

FEBS Lett1987;241:209-12

Start your intake How Insurance Companies Decide GLP-1 Coverage Insurance approval for GLP-1 medications depends on several factors that vary by carrier